Mucosolvan (Ambroxol Hydrochloride)

Ambroxol stimulates serous glands in the respiratory tract, increasing the production of watery secretions that dilute mucus. It also enhances the activity of cilia, the tiny hair‑like structures that move mucus toward the throat. The combined actions lower mucus viscosity and promote effective expectoration, helping to clear the airways.

The appropriate dose of Mucosolvan is determined by a qualified healthcare professional based on the patient’s age, condition severity, and overall health status. Prescribers follow local guidelines and may adjust the regimen for specific populations such as children, the elderly, or individuals with renal impairment.

Safety data for ambroxol during pregnancy are limited, so the drug should only be used if the potential benefit justifies any possible risk to the fetus. While limited information exists for breastfeeding, caution is advised and the infant should be monitored for any adverse effects if the mother chooses to continue treatment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Mucosolvan. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing a formal quotation, availability, shipping details and any necessary import documentation.

Mucosolvan (ambroxol) differs from agents such as N‑acetylcysteine by primarily stimulating serous secretion and ciliary activity, whereas N‑acetylcysteine acts as a direct chemical reducer of disulfide bonds in mucus. Ambroxol often has a more favorable taste profile and may provide mild anti‑inflammatory effects, making it a preferred option for some clinicians.

Mucosolvan should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or direct sunlight.

Mucosolvan is taken orally, usually with a glass of water. It can be swallowed with or without food, depending on the prescriber’s advice. Patients should follow the specific instructions provided by their healthcare professional regarding timing and whether to take it on an empty stomach.

The most serious adverse reactions include allergic responses such as rash, itching, swelling, or anaphylaxis, as well as severe skin conditions like Stevens‑Johnson syndrome. Hepatic enzyme elevations and blood dyscrasias (e.g., neutropenia or eosinophilia) are also rare but important to monitor. Immediate medical attention is required if any of these symptoms appear.

Mucosolvan is contraindicated in individuals with known hypersensitivity to ambroxol or any of the product’s excipients. Patients with a history of severe allergic reactions to mucolytics should avoid it. Caution is also advised for those with uncontrolled asthma, severe renal impairment, or who are pregnant or breastfeeding without clear medical justification.